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Abstract 
 There is a need to innovate with new management tools to be 
disseminated both in the public health and in the private sector. The ways to 
contain health care expenditure, normally involve a decrease in the quality of 
services. Some of the measures are commonly adopted patient co-pay 
schemes, or practicing de-facto rationing, either by limiting the number of 
actual treatments provided in combination with long waiting lists, or carrying 
out consumer health campaigns focused on prevention, all with the aim of 
limiting the demand for public health services. Major industrialized countries 
have focused on reforming health care to cut costs rather than implementing 
policies to improve the health of their populations and thus stimulate national 
economic growth. Low cost-high value services are the answer firstly, to an 
individual’s desire for personalized health care and secondly, to the inability 
of the western health care systems to respond to this change. Low Cost- High 
Value companies are new entries in those areas of the competitive system 
left vacant by the welfare state and they meet the patient’s new needs to 
safeguard health with out of pocket payment. Often they are prime mover 
companies that launch innovations, invest in the development of new 
products and accept the risk of exploring unknown territory. The analysis of 
two case studies: Centro Medico Sant’Agostino and Odontosalute, highlights 
that the traditional health care business model and the low cost high value 
are significantly different in several points of their chain of values.) 
 
Keywords: Health, low cost-high value, opportunity cost, case works, prime 
mover 
 
Introduction 
 The purpose of this study is to analyze two companies that have 
chosen to operate in the field of low cost/high value health services, 
(Eisenhard, 1989). Companies operating in health services of the low 
cost/high value type are new entries in an area of the competitive system left 
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vacant by the shift of the welfare state from universal health care to a more 
selective system. However, this new course is not accompanied by new 
choices, even though the consumer/patients would like to see their needs met 
with a new range of options for which, despite their shrinking incomes, they 
are willing to pay out of pocket to safeguard their health. The  patients pay 
directly for dental services, the counter drugs, diagnostic services and a 
majority of specialist visits. People are often encouraged to opt for paid 
services privately in order to ensure faster access at the cares (Fattore & 
Ferré, 2012). Many times these companies are first movers that introduce an 
innovation to the field, carrying the expense of developing a new product 
and the risks of exploring unknown territory. A possible answer to the needs 
of population who need to care are companies low cost high value. It is the 
long waiting time involved in public health services which leads people 
concerned with the cost of opportunity to turn to privately paid health 
services. These companies responding to the choices of the major 
industrialized countries have focused on health care reform to reduce costs, 
rather than implement policies to improve the health of their populations and 
stimulate national economic growth as well. The difficulties of the welfare 
state can not find an adequate response to the hoped-for recovery. In fact, the 
crisis of the creation of  new jobs, inequality and the blocking of social 
mobility generate a terrible attack on two fronts at the Italian welfare. The 
first is in terms of funding, because fewer workers means less income to be 
taxed and less resources from which social services can be paid; the second 
on the demand side of performance, because it is the request of unemployed 
with no income, and the demand from those who work but still have 
insufficient income. It is the systemicity crisis enveloping the welfare which 
may explain the shocking numbers: Italians renounce at  health services, 
especially those employed but in absolute poverty; so welfare is working 
contrarily to the original mission: instead of moderating, amplifying social 
inequalities (Censis, 2016). Furthermore there are many effects that derive 
from access to good health like increased productivity, since workers feel 
more physically and mentally more efficient and energetic or a decrease in 
the number of sick days and days off of work to care for family members 
who are ill, (Suhrcke & Martin McKee, 2005). Low Cost High Value 
companies are new entries in those areas of the competitive system left 
vacant by the welfare state and they meet the consumer/patient’s new needs 
to safeguard health with out of pocket payment (Kachaner et al., 2010). Low 
cost health care providers, encouraged by the opening up of new market 
areas, particularly those in the lightweight care areas, are privileged 
correspondents of voluntary health care funds, while accredited private 
providers and the National Health Service itself often find it difficult to 
conform to the operating systems of company health funds which take into 
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consideration things like on-line appointments, short waiting lists and even 
pleasant environments, (Cinosi & Rizzo 2013) 
 
Organization and Research Method 
 We want to prove that there is a new sector that stands between the 
public and private health care: the health care low cost high quality. The 
specific objective and the ultimate goal of the research that we resolved, is to 
be put in benchmarking, through the study of cases (Hartley, 1994), which 
may act as a guide for those who want to go down this road or want to 
improve their corporate policies in view of low cost high value in order to 
meet the requirements of good health. This work may act as a guide for those 
who want to go down this road or want to improve their corporate policies in 
view of low cost high value in order to meet the requirements of good health. 
According to Porter and Lee (2013), the value is defined as “health outcomes 
achieved that matter to patients relative to the cost of achieving those 
outcomes”. In the research an analysis of changing economic and political 
choices in health care will be highlighted. Following Hibbard et al. (2012) 
we consider that achieving better health outcomes at lower cost is a major 
objective of many initiatives in health care. 
 The adoption of a descriptive research design, fieldwork and 
qualitative method is the default choice in the structuring of research and 
considered appropriate to achieving the objectives of the work. To define the 
business model for Low Cost High Value in health care providers, case 
studies are considered the most effective course to come up with answers to 
“how” and “why” questions when researchers have only limited control over 
events, but at the same time want to explore con-current trends with the aim 
of explaining certain phenomena and casual relationships. This is the reason 
why case studies and real stories are the research strategies that are most 
suitable to this kind of study. Yin (2003) suggested applying the logic of 
“literal e theoretical replication”, which is based either on the identification 
of cases that will give similar results (literal replication ) or which will give 
different results, but for predictable reasons (theoretical replication). The 
importance of this logic is that it allows for the extension or replication of the 
emerging theory. In our case we have chosen the “literal replication” 
analyzing two kinds of companies active in the low cost/high value sector to 
find their similarities. They are Italian companies working in northern Italy: 
the Centro Medico Santagostino Milan in Lombardy, and OdontoSalute 
Gemona in Friuli - Venezia Giulia. They are companies that have adopted 
the low cost/high quality philosophy by focusing on improving their 
organization and creating economies of scale to cut costs, thus making health 
services available to a wider range of consumers. Both companies adhere to 
the ethical code (Gazzola & Mella 2015) drawn up by the AssoLowcost and 
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so, while adopting different business strategies, they must follow similar 
parameters, (Wirtz, Iacovone & Lovelock, 2013) 
 
The Opportunity Cost Choices in Health Care 
 Major industrialized countries have focused on reforming health care 
to cut costs rather than implementing policies to improve the health of their 
populations and thus stimulate national economic growth. 
 Containing health care expenditure can be done in many ways, 
however they all involve a decrease in the quality of services. Some of the 
measures commonly adopted are patient co-pay schemes, or practicing de-
facto rationing, either by limiting the number of actual treatments provided 
in combination with long waiting lists, or carrying out consumer health 
campaigns focused on prevention, all with the aim of limiting the demand for 
public health services. Resources are limited and the Italian National Health 
Service is struggling to deal with many problems like inadequate treatments 
due to insufficient staff and long waiting lists, mainly caused by lack of 
hospitals, inefficient bureaucracy, poor management and general dis-
organization which all contribute to cost increases, (Querci, 2014 b). 
 It is important to define the difference in meaning between waiting 
lists and the lapse of time that occurs before a service is provided; the first 
refers to the number of patients in line while the second refers to the time 
patients must wait from the moment they join the line to the moment when 
they actually receive treatment, (Sanmartin et al., 2003). Striving to reach a 
point of balance between waiting lists and waiting time is rather complex 
since there is no direct benefit to be gained by increasing productivity; while 
this might lead to shorter waiting time it does not automatically shorten 
waiting lists which, on the contrary, might lengthen. This is due to the 
phenomena known as supply-induced demand where an increase in supply 
can lead to an increase in demand, generated by the perception that reduced 
waiting time means better quality. Therefore, it is waiting time that is an 
indicator of an excess of demand in relation to supply. 
 The private opportunity cost increases for as long as the waiting time 
increases, since it is impossible to carry out normal daily activities like work, 
housework and free time activities. Equally important is the time involved in 
obtaining treatment like waiting time, travel time and last, but not least, the 
anxiety and uncertainty involved in not knowing when treatment will be 
provided. It is therefore the long waiting time involved in public health 
services which leads people concerned with the cost of opportunity to turn to 
privately paid health services, (Rebba, 2009). 
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Figure 1 - Waiting times and choice between public and private: a comparison between two 
different opportunity costs of time.  
 
Source:  Rebba, 2009 
  
 Figure 1 highlights the difference between two inclined straight lines, 
CH and CL, where the first one refers to a subject H, with high cost-
opportunity , and the second to a subject L, with low cost-opportunity. For 
both subjects it is initially hypothesized that the expected benefits from 
treatment B remain constant in time and are always above the price P.  In 
general, an individual will choose free public health care when the expected 
waiting time is such that the cost-opportunity of the service is less than the 
price P of the service provided by private providers. As waiting time 
increases, the performance of the line, with reference to time cost-
opportunity, overtakes the price P and in this case an individual might decide 
to turn to a private provider to obtain treatment.  
 Subject H, with a high level of time cost-opportunity, will place a 
limit on the position assigned by the public health service, that is to say, if it 
is within the time limit th, however if waiting time shifts towards t°, his 
choice may immediately move towards private treatment at a price P. L, 
whose cost opportunity is lower, will turn to a private provider only if the 
waiting time of the public health provider is longer than tL. The choice in 
favour of paid health care does not necessarily imply that H has a higher 
income than L, but only that H might be self-employed with low income, so 
the impossibility of obtaining health care in a short time might lead to a loss 
of income, while L, with a higher income is drawn to the private sector 
because of the costs of anxiety. If H is not able to afford the payment of price 
P he will have to endure a reduction of efficiency caused by the loss of well-
being as a consequence of having to stop working for the time t°.  
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 The free Public Health System might manage to ration a specific 
health treatment through the practice of long waiting lists when there is a 
private alternative with no waiting lists and competitive prices, (Querci, 
2014a). Who pays out-of-pocket health care often does so for the long 
waiting lists. This is due to the phenomena known as supply-induced demand 
where an increase in supply can lead to an increase in demand, generated by 
the perception that reduced waiting time means better quality. Therefore, it is 
waiting time that is an indicator of an excess of demand in relation to supply, 
(Boutsioli, 2010).   
 
Reducing Waiting Time in Health Care  
 The OECD reports (2015) a general decline in health expenditure and 
the adoption of containment measures in Italy as a result of the economic 
crisis. Such containment measures exhort citizens to use the out of pocket 
private health care. The spending out of pocket in Italy (3.2%) is higher than 
the OECD average (2.8%), Figure 2 (Aceti & Squillace, 2016).    
Figure 2 - Out of pocket  medical spending as a share of final  households consumption, 
2013 (or nearest year) 
 
Source: OECD, 2015 
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 It is necessary to specify that the waiting time between public, private 
or the low cost high value healthcare is different. The comparison of the data 
CENSIS (2015) with the retail prices offered by the Low Cost High Value 
showed the cost of each day of waiting time for a medical examination. 
Every single day of waiting spared by purchasing private facilities rather 
than public ones will cost from € 4.2 to € 28, depending on the service. Cost 
and waiting time have inverse trends in the transition from public to private. 
Infact the increase of the cost in the private services corresponds to a 
decrease in waiting time and vice versa. Table 2 shows that a gynaecological 
examination costs € 30.7 in the public sector, while € 103.3 in the private, 
but with different waiting times. The waiting time is 5.4 days in private and 
38.3 days in public sectors, and, compared to a cost of € 60, the waiting time 
of high to low-cost value is 7 days. The waiting time is the hidden cost that 
affects the choice of citizens to use the private sector, profit or non profit, 
(Table 1) (Querci & Gazzola, 2106).  
Table 1 - Comparing costs between public health, private and low cost high value 
Cost in euro  
(2015) 
Public  
ticket* 
Intramoe 
nia* 
Private* Centro 
medico 
Santagostino 
low cost 
high value** 
Odonto 
Salute 
low cost 
high 
value*** 
Specialist visits      
Before cardiological 
examination with Ecg 
41.70 113.50 108.10 80.00  
gynecological examination 30.70 99.80 103.30 60.00  
orthopaedic examination, 31.70 101.90 103.60 60.00  
first eye examination 42.50 105.10 102.40 60.00  
Diagnostic examinations      
Full abdomen ultrasound 56.30 102.20 110.00 60.00  
Psa prostate specific 
antigen 
13.80 19.30 18.80 13.80  
Laboratory analysis      
total cholesterol 4.90 7.60 7.30 1.70  
complete blood count 6.80 11.40 10.00 4.05  
Dental visits      
simple tooth extraction with 
anaesthesia 
24.90 76.10 88.00  45.00 
 two-channel root canal 48.10 182.10 179.00  100.00 
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treatment 
tartar removal 16.40 55.10 88.00  40.00 
source:*censis.it;**http://www.cmsantagostino.it;***http://www.odontosalute.it. 
 
Private health Care, Low Cost High Value 
 This is mainly due to the shift from the National Health Service to the 
private sector and to the trends towards privatization occurring on a global 
scale. This has led to an attempt to overcome the economic downturn due to 
the privatization of assets and services, which used to be protected from 
commercialization, through the creation of new areas of market and the 
expansion of existing ones by increasing their profitability. 
 Long-term profitability is mainly guaranteed in the local public sector 
and in the social health services, due to their largely unvarying demand. The 
variety of companies that are involved in the health services system are the 
accredited private provider, the so-called” private to private” health care 
provider, among which there are those that adhere to the low-cost 
philosophy, and the foreign health care provider that caters to the medical 
tourism industry. There are also providers of many additional kinds of health 
insurance that can be complementary to, supplementary to, or duplicative of 
that of the National Health System.  
 Therefore the opening up of the market to a third kind of 
“lightweight”  private health care, positioned between the public and the 
private sectors, as well as the inclusion in some national trade union 
agreements of voluntary health care funds, is one of the paths chosen to 
provide an alternative to national health systems. These national systems are 
in constant financial distress due to the imbalance between income and 
expenditure which results in ever increasing cuts in spending. Low-cost 
health care providers, encouraged by the opening up of new market areas 
(Pessina et al., 2011), particularly those in the lightweight care areas, are 
privileged correspondents of voluntary health care funds, while accredited 
private providers and the National Health Service itself often find it difficult 
to conform to the operating systems of company health funds which take into 
consideration things like on-line appointments, short waiting lists and even 
pleasant environments. Low cost high value companies have entered the 
market just at the moment when a new field is opening up and they offer 
advanced technology, good organization, pleasant accommodation and the 
ability to fulfil the demands of that new field. Their company mission is to 
provide low cost quality health care while at the same time meeting the 
commitment of company health funds to provide the required services to 
their members.   
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 Health care companies in the low cost high value field share goals of 
long term economic viability, as well as that of total independence from the 
National Health Service. Prices of services are on average 30% lower than 
the price of private traditional health and sometimes inferior to the public 
ticket (Cinosi & Rizzo, 2013). Many times these companies are first movers 
that introduce an innovation to the field, carrying the expense of developing 
a new product and the risks of exploring unknown territory. The definition of 
first mover is ambiguous because, if a company moves into a consolidated 
market but takes advantage of certain technological gaps or sectors where 
there is a new demand, can it be considered a first mover? Can this be 
classified as the first move? There are no published answers to this question 
but from the data of the PIMS (Profit Impact of Market Strategy) it appears, 
for instance, that more than half of all the business units are “pioneers” 
among several competitors within the same market area (Querci, 2016) 
 The advantage of being first movers lies in the ability of the company 
to be in a pole-position to gain economically and this can be reached through 
several stages. In the first stage a particular advantage of the pioneer over its 
rivals can usually be attributed to some variable such as unique resources, or 
a particular foresight, or even just to a stroke of luck. Once this variable 
occurs, a series of mechanisms allow the company to take advantage of its 
position to increase the scope, or the length, of its profit as a first moverIt is 
important to bear in mind that in certain markets there is only room for a 
limited number of profitable enterprises so the first move is to select the 
most interesting niche sectors and then to put into effect those strategies that 
will limit the space available to further competitors (Lieberman & 
Montgomery, 1988). The next step is to pass from narrow and traditional 
skills to the wider and newer skills necessary, at the same time as the rules of 
the game are being re-written. R. Norman (2002) calls prime mover 
innovator/inventor those individuals that he considers “creators of sleeping 
assets markets". The prime mover transforms these assets into liquidity that 
can be advantageously employed in a different context. In this sense the 
prime mover makes all the players richer, leading others to identify untapped 
assets to be exploited, such as, in the realm of low cost high value health 
services, short waiting lists, comfortable accommodation and convenient 
geographical locations. They have a new approach as subjects capable of 
impacting on the outside environment. They are organizations that don’t only 
understand the changing market but, in some ways, implement or direct the 
change itself (Norman, 2002) The prime mover has considerable advantages, 
among them technological leadership, learning curves, brand identification, 
as well as the opportunity to shift the switching expenses on to the client and 
the chance to exploit the positive effects generated by customer satisfaction. 
The leading company that is the first to invest in new technology, 
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particularly when this involves skills, will enjoy a preeminent position 
among its competitors, at least until they are able to reach the same levels of 
skills.  
 
Case Study 
 The two cases studied, Centro Medico Sant’Agostino and 
OdontoSalute, though offering different types of goods and services, shared 
certain common elements like business strategies, the organization of their 
supply chains and customer satisfaction and orientation. The two companies 
are characterized by profit margins based on industrial production; dental 
prosthesis and specialties for the Centro Medico Sant’Agostino and dental 
care and prosthesis for OdontoSalute. The Table 2 compares their strong 
points.  
Table 2 - Commercial strong points of the Centro Medico Santagostino, and  the 
OdontoSalute 
 Centro Medico SantAgostino OdontoSalute 
Born 2009 2008 (born like Progetto Dentale 
Apollonia (in June 2013 changed its 
name to OdontoSalute) 
Their mission:  “Health at the right price”  “With us a smile costs less” 
Market share: Meets the growing consumer need 
for high quality specialized 
medicine that is economical and 
accessible. 
Services at affordable prices to 
contrast medical tourism  output by 
offering patients local care at fair 
prices and import patients from other 
countries 
Price: Prices are 30% to 40% below 
comparable market prices. 
Prices are 30% to 40% below 
comparable market prices. 
Customer 
satisfaction 
and 
orientation:  
Patients seeking good health care 
with waiting lists of one week or 
less, in pleasant surroundings to 
get quality care with minimum 
stress 
The strategies to contain costs 
benefit patients who are offered 
quality services at lower prices than 
those of the competition, with 
minimum waiting lists and easy 
access to care. 
Location: 7 locations with 3 clinics that offer 
more than 30 specialties. In the 
center of Milan, the offices are 
easy to reach and cater to a vast 
and diverse socio-economic 
clientele.   
21 locations, in north, center and 
south Italy, ample parking, near 
airports, and motorway exits, very 
diverse socio-economic clientele. 
seven clinics are owned by other 
franchise agreements 
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Type of goods 
and services: 
  
Out-patient surgery furnishing 
careful and individual attention, 
aimed at supporting patients in 
every aspect of their care, 
especially the doctor/patient 
relationship, with plenty of time 
for dialogue, free consulting 
services and transportation, child 
care areas.  
Highly specialized dental clinic with 
state of the art equipment. Provides 
medical tourism services for 
foreigners seeking treatment in Italy. 
Source: author's elaboration 
 
 The cases analyzed (Eisenhard, 1989) are all in line with the 
parameters of the study, in fact they all adhere to the low cost/high value 
philosophy, all offer, either directly or indirectly, a variety of health services 
or medical prosthesis, they operate in different geographical areas and they 
are first movers. They are successful in the competitive market and are 
financially secure. They are providers for private care insurance policies, 
associations and company health care plans, or other organizations that could 
potentially become partners. In their performance, the two companies share a 
common organizational model, (Cinosi & Rizzo, 2013). For management 
and non-management personnel, paramedics and doctors, the two companies 
review performance, raise salaries and grant promotions on the basis of 
merit. Implementing organizational routines in the offices guarantees quality 
and efficiency and is useful when opening new branches or franchise 
ventures. Career and economic incentives are offered mainly to professional 
employees; at the OdontoSalute doctors are granted commissions on a 
percentage of the prosthetic work they perform, in the Centro Medico 
Santagostino, upward career mobility is the incentive. The IT systems are 
suitable and convenient for the type of business involved and, with cost 
control in mind, they use standard programs modified to suit specific 
demands. Branches are designed with functional features in mind, so as to 
provide efficient work environments and services.  
 If on one hand venues are designed with people in mind, taking into 
account hospitality and good use of space, on the other hand the layout is 
functional to containing costs. The OdontoSalute has come up with clinics 
that make the most of their investments by having 10 to 17 dentists’ chairs 
that work for 6 days a week, in two shifts. In both centers it is possible to 
book on line. The Medical Center Santagostino website states that it 
maintains the waiting time within 3 days from the date of request for all 
visits.While Odontosalute informs the patients that at the entrance to the 
clinic, the customer is provided with a badge that 'counts' the waiting time. 
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Conclusion 
 In health care low cost/high value enterprises offer a satisfactory 
choice of quality services at substantially lower prices. In a society where 
welfare is suffering, and political choices are shifting towards multiple 
providers in health care, the volume of services and turnover of low 
cost/high value care, indicates that people consider it the answer to their 
demand for treatment at fair prices. Where the structure of the health services 
has had a gradual transformation from a network of professionals to a 
network of more industrialized services. These case studies are all virtuous 
examples whose aim is to increase economic turnover while safeguarding 
vulnerable consumers. The appearance of new private enterprises in the 
health market has a positive effect on the nation’s revenues through the 
increase in income from taxation, the growth of job opportunities and real 
estate investments. However, the spread of the phenomena of low cost health 
care has increased the tendency to transform the health services market into 
one like many others, with the risk of generating negative consequences. In 
the comparison of  Censis data (2015) with the retail prices offered by low-
cost high value the cost of each day of time waiting for a medical 
examination evidence that their cost is competitive. These companies 
minimize the increase in the cost of private services with a decrease in the 
waiting time. The health services structures in low-cost high-value offer the 
services substantially characterized by the industrial logic. In fact they 
adhere to the low cost/high value philosophy, offering either directly or 
indirectly, a variety of health services or medical prosthesis, operating in 
different geographical areas and they are first movers. They also are 
providers for private care insurance policies, associations and company 
health care plans, or other organizations that could potentially become 
partners. (Carbone et al., 2010). OdontoSalute has  10 to 17 dental units that 
work for 6 days a week, in two shifts. The Centro Medico Santagostino 
offers dental care up to 10 pm. Large volumes of sales and narrow margins 
are the philosophy of all two companies and suppliers have had to conform 
to this same policy.  It is particularly evident in health care that low cost/high 
value enterprises offer a satisfactory choice of quality services at 
substantially lower prices. In a society where welfare is suffering, and 
political choices are shifting towards multiple providers in health care, the 
volume of services and turnover of low cost/high value care, indicates that 
people consider it the answer to their demand for treatment at fair prices (Del 
Vecchio & Rappini, 2010).  
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